Allmed Solutions Ltd

Tel Aviv Stock Exchange ALMD.TA

Allmed Solutions Ltd Operating Income for the year ending December 31, 2023: USD -920.97 K

Allmed Solutions Ltd Operating Income is USD -920.97 K for the year ending December 31, 2023, a 73.88% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Allmed Solutions Ltd Operating Income for the year ending December 31, 2022 was USD -3.53 M, a -370.24% change year over year.
Allmed Solutions Ltd Operating Income for the year ending December 31, 2021 was USD 1.30 M, a 170.76% change year over year.
Allmed Solutions Ltd Operating Income for the year ending December 31, 2020 was USD -1.84 M, a -128.89% change year over year.
Allmed Solutions Ltd Operating Income for the year ending December 31, 2019 was USD 6.38 M, a 204.21% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Tel Aviv Stock Exchange: ALMD.TA

Allmed Solutions Ltd

CEO	Prof. Oz Shapira
IPO Date	Dec. 24, 2007
Location	Israel
Headquarters	2 Ha'Eshel Street
Employees	19
Sector	Health Care
Industries Pharmaceuticals Medical Instruments

Description

Allium Medical Solutions Ltd. develops, manufactures, and sells long-term, fully covered, expandable, and retrievable stents for the treatment of the various obstructions in the urinary and GI tract in Israel and internationally. The company offers ureteric, bulbar, triangular and round prostatic, and biliary stents. Allium Medical Solutions Ltd. is based in Caesarea, Israel.

Key trends

Past 5 years